Viewing Study NCT00946166


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-26 @ 8:44 PM
Study NCT ID: NCT00946166
Status: WITHDRAWN
Last Update Posted: 2015-04-22
First Post: 2009-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of Statins on Cytokine Expression in Pneumonia
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Study Overview

Official Title: Impact of Statins on Cytokine Expression in Pneumonia
Status: WITHDRAWN
Status Verified Date: 2015-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Investigator left institution.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators are conducting a study to determine the effects of a cholesterol-lowering medication, called simvastatin on pneumonia. People in the study will be in the hospital because they have pneumonia. The people will also have a medical condition like heart disease, diabetes, stroke or high cholesterol for which cholesterol-lowering medication has been shown to prevent future disease and/or death but are not taking a cholesterol-lowering medication when they go to the hospital. Some people will get treated with antibiotics only and other people will get antibiotics and simvastatin while they are in the hospital. The study will compare the effects the combination of simvastatin and antibiotics has on people with pneumonia to treatment with antibiotics alone.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: